CN100572546C - Produce the method for 5-amino-laevulic acid with engineering bacteria - Google Patents
Produce the method for 5-amino-laevulic acid with engineering bacteria Download PDFInfo
- Publication number
- CN100572546C CN100572546C CNB2007100681690A CN200710068169A CN100572546C CN 100572546 C CN100572546 C CN 100572546C CN B2007100681690 A CNB2007100681690 A CN B2007100681690A CN 200710068169 A CN200710068169 A CN 200710068169A CN 100572546 C CN100572546 C CN 100572546C
- Authority
- CN
- China
- Prior art keywords
- engineering bacteria
- culture
- inoculated
- amino
- initial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 241000894006 Bacteria Species 0.000 title claims abstract description 21
- 238000000034 method Methods 0.000 title claims abstract description 14
- 239000002609 medium Substances 0.000 claims abstract description 18
- 238000000855 fermentation Methods 0.000 claims abstract description 14
- 230000004151 fermentation Effects 0.000 claims abstract description 14
- 101150112623 hemA gene Proteins 0.000 claims abstract description 6
- 239000001963 growth medium Substances 0.000 claims abstract 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 12
- ZGXJTSGNIOSYLO-UHFFFAOYSA-N 88755TAZ87 Chemical compound NCC(=O)CCC(O)=O ZGXJTSGNIOSYLO-UHFFFAOYSA-N 0.000 claims description 11
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 7
- 239000004471 Glycine Substances 0.000 claims description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 5
- 239000008103 glucose Substances 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 4
- 241000588724 Escherichia coli Species 0.000 claims description 3
- 102000004867 Hydro-Lyases Human genes 0.000 claims description 3
- 108090001042 Hydro-Lyases Proteins 0.000 claims description 3
- 239000001888 Peptone Substances 0.000 claims description 3
- 108010080698 Peptones Proteins 0.000 claims description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 3
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 claims description 3
- 235000011187 glycerol Nutrition 0.000 claims description 3
- 239000003112 inhibitor Substances 0.000 claims description 3
- 235000019319 peptone Nutrition 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims 2
- 230000001939 inductive effect Effects 0.000 claims 2
- 241000193830 Bacillus <bacterium> Species 0.000 claims 1
- 210000001072 colon Anatomy 0.000 claims 1
- 229940023064 escherichia coli Drugs 0.000 claims 1
- 229940049547 paraxin Drugs 0.000 claims 1
- 235000011149 sulphuric acid Nutrition 0.000 claims 1
- 239000001117 sulphuric acid Substances 0.000 claims 1
- 230000004913 activation Effects 0.000 abstract 1
- 238000001816 cooling Methods 0.000 abstract 1
- 239000006052 feed supplement Substances 0.000 abstract 1
- 229960002749 aminolevulinic acid Drugs 0.000 description 8
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000006698 induction Effects 0.000 description 4
- 238000004321 preservation Methods 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 229940123274 Dehydratase inhibitor Drugs 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 239000003905 agrochemical Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229960005091 chloramphenicol Drugs 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000004095 hydrolyase inhibitor Substances 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 239000001384 succinic acid Substances 0.000 description 2
- 206010005003 Bladder cancer Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- 241000191043 Rhodobacter sphaeroides Species 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 239000012526 feed medium Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 150000003278 haem Chemical class 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 201000002528 pancreatic cancer Diseases 0.000 description 1
- 208000008443 pancreatic carcinoma Diseases 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 150000004032 porphyrins Chemical class 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 201000005112 urinary bladder cancer Diseases 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 238000009333 weeding Methods 0.000 description 1
Images
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
技术领域 technical field
本发明涉及用工程菌生产5-氨基乙酰丙酸的方法。The invention relates to a method for producing 5-aminolevulinic acid with engineering bacteria.
背景技术 Background technique
5-氨基乙酰丙酸(5-aminolevulinic acid,ALA)广泛存在于生物体中,是卟啉生物合成途径中第一个化合物,也是合成血红素、叶绿素、维生素B12等四吡咯化合物的共同前体。ALA作为一种光动力学剂(photodynamic agent,PDT),在农用化学品和医学领域具有广泛的用途。在农业领域,ALA具有除草、杀虫、增加植物抗逆性和促进植物生长等多种功能,并且易降解无残留、对人畜无毒性,成为极具发展前途的无公害绿色农用化学品。在医学领域,ALA具有选择性杀死癌细胞的作用,被称为第二代光动力学药物(photodynamic medicine),具有对正常细胞毒害小,病人避光时间短,疗效好等显著特点,被用于治疗皮肤癌、膀胱癌、结肠癌和胰腺癌等多种癌症。基于ALA的功能和广泛的应用前景,其合成研究已经引起前所未有的重视。5-Aminolevulinic acid (5-aminolevulinic acid, ALA) widely exists in organisms, is the first compound in the biosynthesis pathway of porphyrin, and is also a common precursor for the synthesis of tetrapyrrole compounds such as heme, chlorophyll, and vitamin B12 . body. As a photodynamic agent (photodynamic agent, PDT), ALA has a wide range of uses in the fields of agrochemicals and medicine. In the field of agriculture, ALA has many functions such as weeding, insecticide, increasing plant stress resistance and promoting plant growth, etc., and is easy to degrade without residue, non-toxic to humans and animals, and has become a very promising pollution-free green agrochemical. In the field of medicine, ALA has the effect of selectively killing cancer cells. It is called the second-generation photodynamic medicine (photodynamic medicine). It is used in the treatment of various cancers including skin cancer, bladder cancer, colon cancer and pancreatic cancer. Based on the function and wide application prospect of ALA, its synthesis research has attracted unprecedented attention.
目前ALA的生产较多采用化学合成法,其步骤繁琐、副产物多、产率低且严重污染环境;而生物诱变法生产ALA,主要是利用类球红细菌突变株,所报道ALA的最高产量为27mmol/L,但其培养条件较为复杂,生产周期长,成本较高。At present, the production of ALA mostly adopts the chemical synthesis method, which has cumbersome steps, many by-products, low yield and serious environmental pollution; while the biological mutagenesis method mainly uses the mutant strain of Rhodobacter sphaeroides to produce ALA, and the reported ALA is the highest. The output is 27mmol/L, but its culture condition is relatively complicated, the production cycle is long, and the cost is high.
发明内容 Contents of the invention
本发明的目的是提供一种工艺简单,产量高,对环境友好的用工程菌生产5-氨基乙酰丙酸的方法。The purpose of the present invention is to provide a kind of technique simple, high yield, the method for environment-friendly production 5-aminolevulinic acid with engineering bacterium.
本发明的用工程菌生产5-氨基乙酰丙酸的方法,包括以下步骤:The method for producing 5-aminolevulinic acid with engineering bacteria of the present invention comprises the following steps:
1)用接种针从保藏编号为CGMCC No.1939工程菌Rosetta(DE3)-pET28a-R.S.hemA的甘油管中蘸取菌液,在含有30-50μg/ml卡那霉素和30-50μg/ml氯霉素的LB培养基平板上划线后,置于37℃烘箱中过夜培养;1) Use an inoculation needle to dip the bacterial solution from the glycerin tube with the preservation number of CGMCC No.1939 engineering bacterium Rosetta(DE3)-pET28a-R.S.hemA. After streaking the chloramphenicol LB medium plate, place it in a 37°C oven for overnight culture;
2)将平板上的单克隆接种于含30-50ml LB培养基的250ml摇瓶中,转速为200-220rmp,在37℃过夜培养,得到一级种子;2) inoculate the monoclonal on the plate in a 250ml shake flask containing 30-50ml LB medium, the rotation speed is 200-220rmp, and cultivate overnight at 37°C to obtain first-class seeds;
3)取1ml-5ml一级种子接种于含50-100ml发酵培养基的500ml的摇瓶中培养3-4h,得到二级种子;3) Take 1ml-5ml primary seeds and inoculate them in a 500ml shake flask containing 50-100ml fermentation medium and cultivate them for 3-4h to obtain secondary seeds;
4)将50-100ml二级种子接种于含2-3L发酵培养基的5L发酵罐中进行发酵培养,使罐上的初始菌液密度OD600为0.08-0.2,发酵罐转速为400-600rpm,空气流量为1-2L/min,起始培养温度为37℃,2h后降至26-30℃,再用0.05-0.2mmol/L异丙基-β-D-硫代半乳糖苷诱导;4) Inoculate 50-100ml of secondary seeds into a 5L fermenter containing 2-3L of fermentation medium for fermentation and cultivation, so that the initial bacterial liquid density OD600 on the tank is 0.08-0.2, and the rotation speed of the fermenter is 400-600rpm, The air flow rate is 1-2L/min, the initial culture temperature is 37°C, and after 2 hours, it is lowered to 26-30°C, and then induced with 0.05-0.2mmol/L isopropyl-β-D-thiogalactoside;
5)诱导培养6-10h后流加补料培养基,在菌体密度OD600达到8-12时,分批补加5-氨基乙酰丙酸脱水酶抑制剂继续培养;5) After 6-10 hours of induction culture, the feeding medium was fed, and when the cell density OD600 reached 8-12, the 5-aminolevulinic acid dehydratase inhibitor was added in batches to continue the culture;
6)发酵培养初始采用10%-20%体积分数的稀硫酸控制pH在5.8-6.0;诱导培养4-8h后通过流加补料培养基控制pH为6.1-6.3。6) The initial fermentation culture uses 10%-20% volume fraction of dilute sulfuric acid to control the pH at 5.8-6.0; after 4-8 hours of induction culture, the pH is controlled at 6.1-6.3 by fed-batch feeding medium.
本发明中,所说的保藏编号为CGMCC No.1939工程菌,保藏日期:2007.1.25,分类命名:中文名为大肠埃希氏菌,拉丁文学名为Escherichia coliRosetta(DE3)-pET28a-R.S.hemA,在中国专利局指定的保藏单位中国微生物菌种保藏管理委员会普通微生物中心保藏,保藏单位地址:中国科学院微生物研究所。In the present invention, said preservation number is CGMCC No.1939 engineering bacteria, preservation date: 2007.1.25, classification and naming: Chinese name is Escherichia coli, and Latin literary name is Escherichia coli Rosetta (DE3)-pET28a-R.S.hemA , in the depository unit designated by the Chinese Patent Office, the General Microbiology Center of the China Committee for the Preservation of Microorganisms, and the address of the depository unit: Institute of Microbiology, Chinese Academy of Sciences.
本发明中,所说的初始发酵培养基是由质量体积比分别为0.5%-2%蛋白胨、0.25%-1%酵母粉、0.3%-1%琥珀酸、0.2%-0.4%甘氨酸和0.1%-0.5%葡萄糖组成,其pH值为6.0-6.3;所说的补料培养基中分别含有15-25g琥珀酸和10-15g甘氨酸,体积为800-1000ml;5-氨基乙酰丙酸脱水酶的抑制剂为3-6g/L D-葡萄糖。In the present invention, said initial fermentation medium is composed of 0.5%-2% peptone, 0.25%-1% yeast powder, 0.3%-1% succinic acid, 0.2%-0.4% glycine and 0.1% -0.5% glucose composition, its pH value is 6.0-6.3; Contain 15-25g succinic acid and 10-15g glycine respectively in the said feeding medium, and volume is 800-1000ml; 5-aminolevulinic acid dehydratase The inhibitor is 3-6g/L D-glucose.
本发明工艺简单、可控性高、成本低、发酵过程对环境友好,所得的胞外ALA产量高,具有广阔的工业化前景。The invention has the advantages of simple process, high controllability, low cost, environment-friendly fermentation process, high yield of extracellular ALA, and broad industrialization prospect.
附图说明 Description of drawings
图1胞外ALA浓度及菌体密度OD600与发酵时间的关系曲线。Fig. 1 The relationship curves of extracellular ALA concentration, cell density OD 600 and fermentation time.
具体实施方式 Detailed ways
以下结合实施例进一步说明本发明Further illustrate the present invention below in conjunction with embodiment
实施例Example
用工程菌生产5-氨基乙酰丙酸的方法,包括以下步骤:The method for producing 5-aminolevulinic acid with engineering bacteria comprises the following steps:
1.用接种针从保藏编号为CGMCC No.1939工程菌Rosetta(DE3)-pET28a-R.S.hemA的甘油管中蘸取少量菌液,在含30μg/ml卡那霉素和34μg/ml氯霉素的LB培养基平板上划线,于37℃烘箱中过夜培养;1. Use an inoculation needle to dip a small amount of bacterial solution from the glycerol tube of CGMCC No.1939 engineering bacterium Rosetta (DE3)-pET28a-R.S.hemA, in the presence of 30 μg/ml kanamycin and 34 μg/ml chloramphenicol Streak on the LB medium plate and cultivate overnight in a 37°C oven;
2.挑取单克隆接种于含50ml LB培养基的250ml摇瓶中,转速为200rmp,在37℃过夜培养,得到一级种子;2. Pick a single clone and inoculate it in a 250ml shake flask containing 50ml LB medium at a rotation speed of 200rmp, and culture overnight at 37°C to obtain first-grade seeds;
3.取1ml一级种子接种于含100ml发酵培养基的500ml的摇瓶中,在37℃,200rpm条件下培养3h,得到二级种子。其中初始发酵培养基是由质量体积比分别为1%蛋白胨、0.5%酵母粉、0.3%琥珀酸、0.2%甘氨酸和0.2%葡萄糖组成,用氢氧化钠调节pH值为5.9;3. Take 1ml of primary seeds and inoculate them in a 500ml shake flask containing 100ml of fermentation medium, culture at 37°C and 200rpm for 3h to obtain secondary seeds. Wherein the initial fermentation medium is composed of 1% peptone, 0.5% yeast powder, 0.3% succinic acid, 0.2% glycine and 0.2% glucose in mass volume ratio, and the pH value is adjusted to 5.9 with sodium hydroxide;
4.将100ml二级种子接种于含3L上述发酵培养基的5L发酵罐中,使罐上的初始菌液密度OD600近似为0.1,发酵罐转速为600rmp,空气流量为1.5L/min,起始培养温度为37℃,2h后降至28℃,用0.1mmol/L异丙基-β-D-硫代半乳糖苷(IPTG)诱导;4. Inoculate 100ml of secondary seeds into a 5L fermenter containing 3L of the above-mentioned fermentation medium, so that the initial bacterial liquid density OD600 on the tank is approximately 0.1, the rotation speed of the fermenter is 600rmp, and the air flow rate is 1.5L/min. The initial culture temperature was 37°C, and it was lowered to 28°C after 2 hours, and induced with 0.1mmol/L isopropyl-β-D-thiogalactoside (IPTG);
5.诱导培养4h后流加含有21g琥珀酸和12g甘氨酸,体积为330ml的补料培养基,用菌体的密度监测菌体生长情况,当菌体密度OD600达到8时,开始每隔3h添加4g/L D-葡萄糖作为5-氨基乙酰丙酸脱水酶抑制剂,总共添加3次葡萄糖。6)发酵培养初始pH采用10%-20%体积分数的稀硫酸控制在5.9;诱导培养4h后通过流加补料培养基控制pH为6.2。采用Mauzerall和Granick的分析方法(参照Mauzerall D,Granick S.J.Bio.Chem.,1956,219:435-442)测定ALA的浓度。由图1可见胞外ALA的浓度30h时即可达到6.6g/L。5. Add 21g succinic acid and 12g glycine after 4 hours of induction culture, with a volume of 330ml, and monitor the growth of the bacteria with the density of the bacteria. When the OD 600 of the bacteria reaches 8, start every 3 hours Add 4 g/L D-glucose as a 5-aminolevulinate dehydratase inhibitor, and add
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2007100681690A CN100572546C (en) | 2007-04-20 | 2007-04-20 | Produce the method for 5-amino-laevulic acid with engineering bacteria |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2007100681690A CN100572546C (en) | 2007-04-20 | 2007-04-20 | Produce the method for 5-amino-laevulic acid with engineering bacteria |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101041839A CN101041839A (en) | 2007-09-26 |
CN100572546C true CN100572546C (en) | 2009-12-23 |
Family
ID=38807633
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2007100681690A Expired - Fee Related CN100572546C (en) | 2007-04-20 | 2007-04-20 | Produce the method for 5-amino-laevulic acid with engineering bacteria |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100572546C (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102747114B (en) * | 2012-01-17 | 2014-09-03 | 浙江大学 | Method for regulating recombinant escherichia coli metabolism by using transient anaerobic fermentation |
CN103981203B (en) * | 2013-02-07 | 2018-01-12 | 中国科学院天津工业生物技术研究所 | 5 amino-laevulic acid superior strains and its preparation method and application |
CN104561158B (en) * | 2015-01-13 | 2018-01-16 | 江南大学 | One kind addition Fe2+Improve the method that colibacillus engineering synthesizes 5 amino-laevulic acids |
CN114381416B (en) * | 2022-03-23 | 2022-06-28 | 北京道合成企业管理有限公司 | Recombinant escherichia coli strain for high yield of 5-aminolevulinic acid and application thereof |
-
2007
- 2007-04-20 CN CNB2007100681690A patent/CN100572546C/en not_active Expired - Fee Related
Non-Patent Citations (2)
Title |
---|
5-Aminolevulinate production with recombinantEscherichiacoliusing a rare codon optimizer host strain. Weiqi Fu et.al.Appl Microbiol Biotechnol,Vol.75 No.4. 2007 |
5-Aminolevulinate production with recombinantEscherichiacoliusing a rare codon optimizer host strain. Weiqi Fu et.al.Appl Microbiol Biotechnol,Vol.75 No.4. 2007 * |
Also Published As
Publication number | Publication date |
---|---|
CN101041839A (en) | 2007-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102174449B (en) | Method for producing high-yield gamma-propalanine and application thereof | |
Lu et al. | Enhanced buffer capacity of fermentation broth and biohydrogen production from corn stalk with Na2HPO4/NaH2PO4 | |
CN101633894B (en) | Culture medium of euglena gracilis and open type high-density culture method | |
CN101285047B (en) | A D-lactic acid producing bacterium with high optical purity and its fermentation process for producing D-lactic acid | |
CN102643770A (en) | Escherichia coli for producing succinic acid by utilizing pure anaerobic growth of synthetic culture medium and application thereof | |
CN100572546C (en) | Produce the method for 5-amino-laevulic acid with engineering bacteria | |
Pattanamanee et al. | Repeated-batch production of hydrogen using Rhodobacter sphaeroides S10 | |
CN115637276B (en) | Method for producing tetrahydropyrimidine by using halomonas strain | |
CN101063105B (en) | Engineering bacterium producing 5-glycyl ethylformic acid and construction and application method thereof | |
CN104388484B (en) | A kind of method that microbial grease is produced using volatile fatty acid as fermenting raw materials | |
Guo et al. | Effect of citrate buffer on hydrogen production by photosynthetic bacteria | |
CN105969702B (en) | Serratia marcescens RZ 21-C6 and its application | |
CN102747114B (en) | Method for regulating recombinant escherichia coli metabolism by using transient anaerobic fermentation | |
CN101864389B (en) | Clostridium acetobutylicum strain and screening method and application thereof | |
CN101955978A (en) | Method for improving concentration and production strength of succinic acid by adding osmotic pressure protective agent | |
CN102286580B (en) | Method for producing neoplasm metastasis inhibiting protein GDI2 through escherichia coli accumulation | |
CN101153299B (en) | A kind of fed-batch method for cultivating high-yield microbial oil | |
CN112831437A (en) | Bacillus subtilis and fermentation method with high yield of indole acetic acid and high spore formation rate | |
CN106591398A (en) | Method for obtaining SA by using biodiesel by-product crude glycerol to perform high added-value conversion | |
CN107325975A (en) | Saccharomyces cerevisiae and application thereof in fermentation production of S-adenosylmethionine | |
CN1952164A (en) | Combined fermentation process for producing D-lactic acid | |
CN103773691A (en) | Enclosed rapid culture method of microalgae | |
CN103320367A (en) | Screening and application of high-yield succinic acid escherichia coli by anaerobic utilization of synthetic culture medium | |
CN103146589A (en) | High temperature-resistant yeast strain for producing pyruvic acid and use thereof | |
CN103305437A (en) | L-ammonium lactate tolerant bacterium and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Suzhou Yian Biotech Co., Ltd. Assignor: Zhejiang University Contract record no.: 2010320000856 Denomination of invention: Method for producing 5-glycyl ethylformic acid by using engineering bacterium Granted publication date: 20091223 License type: Exclusive License Open date: 20070926 Record date: 20100705 |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20091223 Termination date: 20200420 |
|
CF01 | Termination of patent right due to non-payment of annual fee |